CSE:PHRM - Post Discussion
Post by
AwareInvestor on Apr 27, 2021 7:55am
PharmaTher Files Patent For Use Of Ketamine In Type 2 Diabet
PharmaTher Holdingshas expanded its patent portfolio. The company this morning announced the filing of a provisional patent application in the US for the novel use of ketamine as a potential treatment for Type 2 diabetes and obesity.
Be the first to comment on this post